戻る Agenda
PAREXEL International Innovation Theater: Developing Drugs in the New Era of Personalized Medicines
Session Chair(s)
Parexel
United States
Over the next five years, personalized medicines in development are expected to increase to nearly 70%, according to the Tufts Center for the Study of Drug Development (TCSDD), potentially improving drug safety and efficacy and also the likelihood of approval. Genomic-guided or supported drug development is a new paradigm requiring companies to think beyond traditional drug development models. This presentation focuses on critical skills to successfully make this transformation.
Speaker(s)
Anita Nelsen
Parexel, United States
Executive Vice President, Translational Medicine
Sy Pretorius, MD, MBA, MS, MSC
Eversana, United States
Chief Operating Officer and President, Outsourced Solutions